scholarly journals Comparison of perioperative short-term outcomes and oncologic long-term outcomes between open and laparoscopic distal pancreatectomy in patients with pancreatic ductal adenocarcinoma

2021 ◽  
Vol 100 (6) ◽  
pp. 320
Author(s):  
Jung Min Lee ◽  
Hongbeom Kim ◽  
Jae Seung Kang ◽  
Yoonhyeong Byun ◽  
Yoo Jin Choi ◽  
...  
Keyword(s):  
Pancreatic Ductal Adenocarcinoma ◽  
Distal Pancreatectomy ◽  
Laparoscopic Distal Pancreatectomy ◽  
Ductal Adenocarcinoma ◽  
Long Term Outcomes ◽  
Short Term

Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection

Surgery ◽  
2017 ◽  
Vol 162 (4) ◽  
pp. 802-811 ◽  
Author(s):  
Mushegh A. Sahakyan ◽  
Song Cheol Kim ◽  
Dyre Kleive ◽  
Airazat M. Kazaryan ◽  
Ki Byung Song ◽  
...  
Keyword(s):  
Pancreatic Ductal Adenocarcinoma ◽  
Distal Pancreatectomy ◽  
Laparoscopic Distal Pancreatectomy ◽  
Oncologic Outcomes ◽  
Ductal Adenocarcinoma ◽  
Standard Resection

Postoperative risk of pancreatic fistula after distal pancreatectomy with or without spleen preservation

2020 ◽  
pp. 030089162093674
Author(s):  
Michele Mazzola ◽  
Jacopo Crippa ◽  
Camillo L. Bertoglio ◽  
Sara Andreani ◽  
Lorenzo Morini ◽  
...  
Keyword(s):  
Pancreatic Fistula ◽  
Distal Pancreatectomy ◽  
Length Of Hospital Stay ◽  
Long Term Outcomes ◽  
Short Term ◽  
Spleen Preservation ◽  
Spleen Preserving ◽  
Postoperative Risk ◽  
Duration Of Surgery

Introduction: Outcomes after distal pancreatectomy with or without splenectomy are controversial. The present study aims to investigate differences in short-term and long-term outcomes between spleen-preserving distal pancreatectomy (SPDP) and distal pancreatectomy with splenectomy (DPS). Methods: In this retrospective review of consecutive patients undergoing distal pancreatectomy with or without splenectomy from January 2011 until December 2017 for benign disease, the primary endpoint was to compare postoperative pancreatic fistula (POPF). The secondary endpoint was to compare duration of surgery, intraoperative blood loss, postoperative complications, length of hospital stay, and long-term outcomes. Results: Patients undergoing SPDP had a lower rate of POPF (13.6% vs 46.1%; p = 0.02). Patients undergoing SPDP (n = 22) were discharged earlier than patients undergoing DPS (n = 26) (8 [4–29] vs 12 [6.48] days; p = 0.003). No differences in other intraoperative and postoperative outcomes were found between groups. Conclusion: Patients undergoing SPDP developed fewer POPF and were discharged earlier compared to patients undergoing DPS.

scholarly journals Short- and long-term outcomes after pancreatectomy for pancreatic ductal adenocarcinoma in octogenarians

Suizo ◽  
2019 ◽  
Vol 34 (5) ◽  
pp. 195-205
Author(s):  
Kensuke NITTA ◽  
Yusuke WATANABE ◽  
Sho OKUDA ◽  
Sho ENDO ◽  
Shingo KOZONO ◽  
...  
Keyword(s):  
Pancreatic Ductal Adenocarcinoma ◽  
Ductal Adenocarcinoma ◽  
Long Term Outcomes ◽  
Short And Long Term

Incidentally discovered pancreatic ductal adenocarcinoma: Is detection of asymptomatic cancer associated with better outcomes than symptomatic cancer?

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 243-243
Author(s):  
Yoshinori Takeda ◽  
Akio Saiura ◽  
Yoshihiro Mise ◽  
Takeaki Ishizawa ◽  
Yosuke Inoue ◽  
...  
Keyword(s):  
Early Detection ◽  
Pancreatic Ductal Adenocarcinoma ◽  
Surgical Resection ◽  
Early Stage ◽  
Ductal Adenocarcinoma ◽  
Incomplete Resection ◽  
Long Term Outcomes ◽  
Potential Implication ◽  
Treatment Type

243 Background: The number of incidentally discovered asymptomatic pancreatic ductal adenocarcinoma (APDAC) has been increasing along with recent wide spread use of imaging studies in general practice. However, the clinical implication in early detection of asymptomatic pancreatic cancer remains yet to be determined. In this study, we reviewed our experience of patients with PDAC in high volume cancer center and compared the characteristics and long-term outcomes between those with APDAC and symptomatic PDAC (SPDAC). Methods: This retrospective study included 569 consecutive patients with PDAC initially treated in our institution from January 2007 to December 2012. Median follow-up period was 29 months for the survivors. Two hundred and fifty patients underwent surgical resection and 319 patients were deemed unresectable. The patient’s demographics, tumor locations, pathologic stages, and treatment type received, and the overall survival (OS) were compared between the patients with APDAC and those with SPDAC. Results: One hundred and sixty-three patients (29%) presented without any subjective symptoms. When compared with SPDAC, APDAC was associated with early stage (stage I, 6% vs. 1%, p<0.01). Among 163 patients with APDAC, 104 patients (64%) underwent surgical resection, while only 146 patients (36%) out of 406 SPDAC underwent resection ( p<0.01). The 5-year OS rate of the patients with APDAC was 18%, comparing with 7% for those with SPDAC ( p<0.01). Among the patients who underwent resection, the presence of symptoms did not affect the chance of incomplete resection (R1, 12% vs. 22% for patients with APDAC and SPDAC, respectively, p=0.06) and the 5-year OS rate (23% vs. 22%, p=0.09). However, the patients with SPDAC required complex operation (concomitant vascular resection and reconstruction 56% vs. 29% for those with APDAC, p<0.01). Conclusions: Asymptomatic PDAC is associated with better long-term outcomes than symptomatic PDAC due to early stage at presentation and higher chance of resectability. Our findings highlight the potential implication of screening program for early detection of PDAC for selected high-risk patient population.

Sign in / Sign up

Export Citation Format

Share Document